Skip to content

Author

M. Marchetti

We have 2 of 173 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

CO015 | EVOLUTION OF ANTICOAGULANT THERAPY FOR CANCER-ASSOCIATED THROMBOSIS: THE START2 REGISTRY ONCO-VTE LONGITUDINAL STUDY

Background. Managing anticoagulant therapy in cancer-associated thrombosis (CAT) remains a clinical challenge, balanced between the heightened risks of recurrent venous thromboembolism (VTE) and major bleeding. The START2 Registry ONCO-VTE provides prospective, real-world evidence from patients with active malignancies...

M. Marchetti · 0 citations
Open access Oct 2026

CO010 | MAPPING HEMOSTATIC BIOMARKER EXPRESSION ACROSS CANCER TYPES AND STAGES WITHIN THE HYPERCAN COHORT

Background and Aims. Systemic hypercoagulability is a recognized hallmark of malignancy. Growing evidence suggests that markers of hemostatic activation may serve as surrogates for tumor aggressiveness and prognosis, other than thrombosis; however, a comprehensive characterization of this "hemostatic signature" within...

M. Marchetti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.